000 01474 a2200421 4500
005 20250517212802.0
264 0 _c20181127
008 201811s 0 0 eng d
022 _a1460-2423
024 7 _a10.1093/glycob/cwy035
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMelo, Ashanty M
245 0 0 _aNovel thioglycoside analogs of α-galactosylceramide stimulate cytotoxicity and preferential Th1 cytokine production by human invariant natural killer T cells.
_h[electronic resource]
260 _bGlycobiology
_c07 2018
300 _a512-521 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aGalactosylceramides
_xchemistry
650 0 4 _aHumans
650 0 4 _aInterferon-gamma
_xmetabolism
650 0 4 _aInterleukin-4
_xmetabolism
650 0 4 _aNatural Killer T-Cells
_ximmunology
650 0 4 _aTh1 Cells
_ximmunology
700 1 _aZhang, Lei
700 1 _aDockry, Éilis F
700 1 _aPetrasca, Andreea
700 1 _aGhnewa, Yasmeen G
700 1 _aBreen, Eamon P
700 1 _aMorrissey, Maria E
700 1 _aO'Reilly, Ciara
700 1 _aBruen, Robyn
700 1 _aO'Meara, Andrew
700 1 _aLysaght, Joanne
700 1 _aZhu, Xiangming
700 1 _aDoherty, Derek G
773 0 _tGlycobiology
_gvol. 28
_gno. 7
_gp. 512-521
856 4 0 _uhttps://doi.org/10.1093/glycob/cwy035
_zAvailable from publisher's website
999 _c28319683
_d28319683